Recent Posts
- NULIBRY (fosdenopterin), First and Only FDA-Approved Therapy to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency Type A, Available Exclusively at Biologics by McKesson
- Bridge the Gap Q&A
- FOTIVDA (tivozanib), FDA Approved for Treatment of Relapsed/Refractory Advanced Renal Cell Carcinoma, Available at Biologics by McKesson
- ORGOVYX™ (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson
- A Letter to Our Biopharma Clients About Organizational Changes
Archives
- April 2021
- March 2021
- January 2021
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- August 2019
- July 2019
- March 2019
- December 2018
- September 2018
- July 2018
- June 2018
- May 2018
- February 2018
- January 2018
- June 2017
- March 2017
- February 2016
- November 2015
- February 2015
- December 2014